Beyond knockout: A novel homodimerization-targeting MyD88 inhibitor prevents and cures type 1 diabetes in NOD mice
Keywords: کلیه جنین انسان; Type 1 diabetes; Therapeutics; MyD88; MyD88 inhibitor; DC; MyD88; myeloid differentiation factor 88; T1D; type 1 diabetes; NOD mice; non-obese diabetic mice; DC; dendritic cell; TLR; Toll-like receptor; TIR; Toll-interleukin receptor; CMC; carboxyl methyl